| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 4.82 Billion | USD 8.92 Billion | 6.5% | 2024 |
FrequentlyAsked Questions
The global minimally invasive neurosurgery device market is expected to grow due to rising prevalence of neurological disorders, increasing demand for less invasive procedures, advancements in imaging and robotic-assisted technologies, and growing adoption of endoscopic neurosurgeries.
According to a study, the global minimally invasive neurosurgery device market size was worth around USD 4.82 Billion in 2024 and is expected to reach USD 8.92 Billion by 2034.
The global minimally invasive neurosurgery device market is expected to grow at a CAGR of 6.5% during the forecast period.
North America is expected to dominate the minimally invasive neurosurgery device market over the forecast period.
Leading players in the global minimally invasive neurosurgery device market include Karl Storz GmbH & Co. KG, Olympus Corporation, Conmed Corporation, Richard Wolf GmbH, Boston Scientific Inc., Integra Lifescience Holdings Corporation, Aesculap Division, Smith & Nephew Plc, Medtronic, NICO Corp, among others.
The report explores crucial aspects of the minimally invasive neurosurgery device market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients